Table 3.
Rates of VTE in select studies validating a risk score for chemotherapy-associated VTE
High-risk score, ≥ 3; intermediate-risk score, 1-2; low-risk score, 0.
*Included 4 weekly screening ultrasonographies.
†Enrolled only high-risk patients.
